Published in World Psychiatry on October 01, 2015
The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis. Schizophr Bull (2015) 1.05
Altering the course of schizophrenia: progress and perspectives. Nat Rev Drug Discov (2016) 0.88
Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis. Schizophr Bull (2015) 0.87
Towards a Standard Psychometric Diagnostic Interview for Subjects at Ultra High Risk of Psychosis: CAARMS versus SIPS. Psychiatry J (2016) 0.84
Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome. World Psychiatry (2016) 0.82
Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation. Schizophr Bull (2017) 0.78
Disturbances of the Basic Self and Prodromal Symptoms Among Young Adolescents From the Community: A Pilot Population-Based Study. Schizophr Bull (2016) 0.76
The Reliability and Validity of Liu´s Self-Report Questionnaire for Screening Putative Pre-Psychotic States (BQSPS) in Adolescents. PLoS One (2016) 0.75
Progressive Decline in Hippocampal CA1 Volume in Individuals at Ultra-High-Risk for Psychosis Who do not Remit: Findings from the Longitudinal Youth at Risk Study. Neuropsychopharmacology (2017) 0.75
The Youth Mental Health Risk and Resilience Study (YouR-Study). BMC Psychiatry (2017) 0.75
Why ultra high risk criteria for psychosis prediction do not work well outside clinical samples and what to do about it. World Psychiatry (2017) 0.75
The Clinical High-Risk State for Psychosis (CHR-P), Version II. Schizophr Bull (2017) 0.75
Terrorism, Radicalisation, Extremism, Authoritarianism and Fundamentalism: A Systematic Review of the Quality and Psychometric Properties of Assessments. PLoS One (2016) 0.75
Improving outcomes of first-episode psychosis: an overview. World Psychiatry (2017) 0.75
People meeting ultra high risk for psychosis criteria in the community. World Psychiatry (2017) 0.75
What Is an Attenuated Psychotic Symptom? On the Importance of the Context. Schizophr Bull (2017) 0.75
The effect of cognitive remediation in individuals at ultra-high risk for psychosis: a systematic review. NPJ Schizophr (2017) 0.75
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (2009) 34.99
The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol (2003) 16.17
Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull (2003) 7.11
The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol (2005) 7.06
Letter: Nomogram for Bayes theorem. N Engl J Med (1975) 6.64
Prediabetes: a high-risk state for diabetes development. Lancet (2012) 6.42
Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry (2007) 6.20
Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry (2012) 5.45
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry (2015) 5.38
Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry (2001) 5.35
Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry (2005) 5.17
Rethinking schizophrenia. Nature (2010) 4.85
Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatry (2012) 4.40
The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 4.16
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry (2010) 3.88
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol (2014) 3.81
Severe mental illness in 33,588 prisoners worldwide: systematic review and meta-regression analysis. Br J Psychiatry (2012) 3.61
Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry (2008) 3.15
Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull (2009) 2.90
Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res (2008) 2.45
Predicting risk of breast cancer in postmenopausal women by hormone receptor status. J Natl Cancer Inst (2007) 2.36
Disorder, not just state of risk: meta-analysis of functioning and quality of life in people at high risk of psychosis. Br J Psychiatry (2015) 2.12
Diagnostic performance of narrowed spectrum endoscopy, autofluorescence imaging, and confocal laser endomicroscopy for optical diagnosis of colonic polyps: a meta-analysis. Lancet Oncol (2013) 2.02
Systematic review and pooled analysis of published and unpublished validations of the ABCD and ABCD2 transient ischemic attack risk scores. Stroke (2010) 2.01
Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br J Psychiatry (2005) 1.76
The prevalence of psychosis in epilepsy; a systematic review and meta-analysis. BMC Psychiatry (2014) 1.71
Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull (2012) 1.58
Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis. Heart (2011) 1.49
Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer (1994) 1.46
Prevalence of psychosis in black ethnic minorities in Britain: analysis based on three national surveys. Soc Psychiatry Psychiatr Epidemiol (2014) 1.43
Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept. Schizophr Bull (2009) 1.39
Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res (2006) 1.38
[The Basel Screening Instrument for Psychosis (BSIP): development, structure, reliability and validity]. Fortschr Neurol Psychiatr (2008) 1.31
EPA guidance on the early detection of clinical high risk states of psychoses. Eur Psychiatry (2015) 1.30
Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis. Eur Psychiatry (2012) 1.25
The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer (1996) 1.25
Lessons learned from the psychosis high-risk state: towards a general staging model of prodromal intervention. Psychol Med (2013) 1.20
Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study. Schizophr Bull (2011) 1.17
Attenuated psychosis syndrome: ready for DSM-5.1? Annu Rev Clin Psychol (2014) 1.14
Whither the attenuated psychosis syndrome? Schizophr Bull (2012) 1.12
Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study. J Am Acad Child Adolesc Psychiatry (2013) 1.10
Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index. Arch Intern Med (2006) 1.09
Basic symptoms and the prediction of first-episode psychosis. Curr Pharm Des (2012) 1.05
Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in the general population: Findings from the BEAR and BEARS-kid studies. World Psychiatry (2015) 1.00
Recording of severe mental illness in United Kingdom primary care, 2000-2010. PLoS One (2013) 1.00
Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers. Schizophr Bull (2014) 0.97
Speed of Psychosis Progression in People at Ultra-High Clinical Risk: A Complementary Meta-analysis. JAMA Psychiatry (2015) 0.95
'A rose is a rose is a rose', but at-risk criteria differ. Psychopathology (2012) 0.94
Prevalence and clinical significance of DSM-5-attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern Epidemiological At-Risk (BEAR) study. Schizophr Bull (2013) 0.92
Mental disorders, disability and treatment gap in a protracted refugee setting. Br J Psychiatry (2013) 0.91
Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis. Psychol Med (2013) 0.91
Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms. Schizophr Res (2014) 0.91
Prevalence-dependent diagnostic accuracy measures. Stat Med (2007) 0.89
Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome. Schizophr Res (2012) 0.89
Risk prediction model for colorectal cancer: National Health Insurance Corporation study, Korea. PLoS One (2014) 0.88
Affect recognition in people at clinical high risk of psychosis. Schizophr Res (2012) 0.86
Predictors of length of stay in forensic psychiatry: the influence of perceived risk of violence. Int J Law Psychiatry (2014) 0.85
The Longitudinal Youth at Risk Study (LYRIKS)--an Asian UHR perspective. Schizophr Res (2013) 0.85
Low positive predictive value of the ABCD2 score in emergency department transient ischaemic attack diagnoses: the South Western Sydney transient ischaemic attack study. Intern Med J (2012) 0.83
Early clinical phenotypes, clinical staging, and strategic biomarker research: building blocks for personalized psychiatry. Biol Psychiatry (2013) 0.83
Clinical high-risk state does not predict later psychosis in a delinquent adolescent population. Early Interv Psychiatry (2013) 0.81
Predicting psychosis in a general adolescent psychiatric sample. Schizophr Res (2014) 0.80
Follow-up of subjects with suspected pre-psychotic state in Taiwan. Schizophr Res (2010) 0.80
PORT (Programme of Recognition and Therapy): the first Polish recognition and treatment programme for patients with an at-risk mental state. Early Interv Psychiatry (2014) 0.79
Screening instruments in child and adolescent psychiatry: general and methodological considerations. Eur Child Adolesc Psychiatry (2014) 0.78
The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease. J Geriatr Psychiatry Neurol (2008) 0.78
Incidence of adult onset schizophrenic disorders in the US military: patterns by sex, race and age. Schizophr Res (2011) 0.78
Identifying children and adolescents at ultra high risk of psychosis in Italian neuropsychiatry services: a feasibility study. Eur Child Adolesc Psychiatry (2015) 0.78
Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes. Diabetes Res Clin Pract (2014) 0.77
Predicting the development of schizophrenia. Br J Psychiatry (2012) 0.76
Predicting the development of schizophrenia. Br J Psychiatry (2012) 0.76
Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11DS genetically at high risk for psychosis. Protocol of a randomized, double-blind, placebo-controlled treatment trial. Early Interv Psychiatry (2014) 0.76
Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification. JAMA Psychiatry (2016) 1.75
Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study. JAMA Psychiatry (2014) 1.33
Intensive community outreach for those at ultra high risk of psychosis: dilution, not solution. Lancet Psychiatry (2016) 1.11
Substance use in clinical high risk for psychosis: a review of the literature. Early Interv Psychiatry (2013) 1.06
The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis. Schizophr Bull (2015) 1.05
A stratified model for psychosis prediction in clinical practice. Schizophr Bull (2014) 0.97
Developing psychosis and its risk states through the lens of schizotypy. Schizophr Bull (2014) 0.88
The content of attenuated psychotic symptoms in those at clinical high risk for psychosis. Psychiatry Res (2014) 0.87
Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis. Eur Child Adolesc Psychiatry (2016) 0.87
Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome. World Psychiatry (2016) 0.82
Stress exposure and sensitivity in the clinical high-risk syndrome: initial findings from the North American Prodrome Longitudinal Study (NAPLS). Schizophr Res (2014) 0.81
Coping and the stages of psychosis: an investigation into the coping styles in people at risk of psychosis, in people with first-episode and multiple-episode psychoses. Early Interv Psychiatry (2015) 0.80
Coping as a predictor of treatment outcome in people at clinical high risk of psychosis. Early Interv Psychiatry (2014) 0.80
NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders. Early Interv Psychiatry (2015) 0.77
Clinical high risk for psychosis: gender differences in symptoms and social functioning. Early Interv Psychiatry (2015) 0.77
5-HT3 receptor influences the washing phenotype and visual organization in obsessive-compulsive disorder supporting 5-HT3 receptor antagonists as novel treatment option. Eur Neuropsychopharmacol (2013) 0.76
DSM-5 and the 'Psychosis Risk Syndrome': The DSM-5 proposal is better than DSM-IV. Psychosis (2010) 0.76
Stimulant Medication and Psychotic Symptoms in Offspring of Parents With Mental Illness. Pediatrics (2015) 0.76
Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis. Soc Psychiatry Psychiatr Epidemiol (2016) 0.75
Psychometric properties of the Trauma and Distress Scale, TADS, in an adult community sample in Finland. Eur J Psychotraumatol (2016) 0.75
The usefulness for indicated prevention of severe mental disorders should play a central part in the further development of CBT. World Psychiatry (2014) 0.75
The Violent Content in Attenuated Psychotic Symptoms. Psychiatry Res (2016) 0.75
Exercise practices in individuals at clinical high risk of developing psychosis. Early Interv Psychiatry (2013) 0.75
The role of a family history of psychosis for youth at clinical high risk of psychosis. Early Interv Psychiatry (2017) 0.75
Changes in symptom content from a clinical high-risk state to conversion to psychosis. Early Interv Psychiatry (2017) 0.75
Predictors of treatment response to psychological interventions in people at clinical high risk of first-episode psychosis. Early Interv Psychiatry (2017) 0.75
Duration of unspecific prodromal and clinical high risk states, and early help-seeking in first-admission psychosis patients. Soc Psychiatry Psychiatr Epidemiol (2015) 0.75
Exploration of clinical high-risk dropouts. Schizophr Res (2017) 0.75
Course of clinical high-risk states for psychosis beyond conversion. Eur Arch Psychiatry Clin Neurosci (2017) 0.75
Perceptual abnormalities in clinical high risk youth and the role of trauma, cannabis use and anxiety. Psychiatry Res (2017) 0.75
The Role of microRNA Expression in Cortical Development During Conversion to Psychosis. Neuropsychopharmacology (2017) 0.75
Distress in relation to attenuated psychotic symptoms in the ultra-high-risk population is not associated with increased risk of psychotic disorder. Early Interv Psychiatry (2015) 0.75
Negative schemata about the self and others and paranoid ideation in at-risk states and those with persisting positive symptoms. Early Interv Psychiatry (2017) 0.75
Basic auditory processing and emotion recognition in individuals at clinical high risk for psychosis. Schizophr Res Cogn (2021) 0.75
Increased Striatal and Reduced Prefrontal Cerebral Blood Flow in Clinical High Risk for Psychosis. Schizophr Bull (2017) 0.75
Depression predicts persistence of paranoia in clinical high-risk patients to psychosis: results of the EPOS project. Soc Psychiatry Psychiatr Epidemiol (2015) 0.75
The Italian version of the 92-item Prodromal Questionnaire: Concurrent validity with the SIPS and factor analysis in a sample of 258 outpatients aged 11-36years. Schizophr Res (2017) 0.75
What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a "real-world" 2-year follow-up trial. Eur Arch Psychiatry Clin Neurosci (2019) 0.75
Characterizing sustained social anxiety in individuals at clinical high risk for psychosis: trajectory, risk factors, and functional outcomes. Psychol Med (2022) 0.75